Abstract

Management of a pre-existing mechanical mitral valve prosthesis during durable left ventricular assist device (LVAD) implantation remains controversial. Retaining the prosthesis may predispose to leaflet immobility, thrombosis, and inflow obstruction, whereas full prosthetic replacement adds substantial operative risk, particularly in redo cardiac surgery. We describe a novel surgical strategy combining removal of the mobile prosthetic components with preservation of the sewing ring during HeartMate 3 implantation. A 49-year-old woman with advanced heart failure and previous mechanical mitral valve replacement underwent HeartMate 3 implantation with concomitant tricuspid annuloplasty. The prosthetic leaflets and visible pivot components were intentionally fractured and removed, while the sewing ring was preserved in situ. At 12-month follow-up, the patient remained clinically stable without thromboembolic events, device malfunction, or inflow obstruction. This strategy may represent a feasible alternative to complete prosthetic replacement in selected redo patients.

Introduction

Management of a pre-existing mechanical mitral valve prosthesis during durable left ventricular assist device (LVAD) implantation remains controversial. Retention of the prosthesis may predispose to leaflet immobility, thrombosis, and inflow obstruction under continuous-flow conditions, whereas complete prosthetic replacement increases operative complexity and surgical risk, particularly in redo procedures [1–3]. We describe a novel surgical strategy during HeartMate 3 implantation consisting of intentional removal of the mechanical valve leaflets and visible pivot components while preserving the prosthetic sewing ring in situ. To our knowledge, this is the first reported case using this technique.

Case presentation

A 49-year-old woman with previous mechanical mitral valve replacement, prior percutaneous coronary intervention, and implantable cardioverter-defibrillator implantation presented with progressive exertional dyspnea, peripheral edema, and ascites despite optimal medical therapy. On admission, clinical examination demonstrated volume overload with elevated jugular venous pressure and bilateral lower-extremity edema. The patient was categorized as INTERMACS profile 3, indicating advanced heart failure requiring durable mechanical circulatory support. Transthoracic echocardiography demonstrated severe biventricular dysfunction with a left ventricular ejection fraction of 18%, severe functional tricuspid regurgitation, and preserved mobility of the mechanical mitral prosthesis. Right heart catheterization confirmed elevated filling pressures and increased risk of postoperative right ventricular failure. Following preoperative optimization with intravenous diuretics and inotropic support, the patient underwent HeartMate 3 implantation with con-comitant tricuspid annuloplasty. Through a transseptal approach, the

mechanical mitral prosthesis was inspected intraoperatively. Because of concerns regarding leaflet immobility, thrombosis, and potential inflow obstruction after LVAD activation, the metallic leaflets and visible pivot components were intentionally fractured and removed, while the prosthetic sewing ring was preserved in situ (Fig. 1). This approach avoided complete prosthetic explantation and maintained annular integrity. The postoperative course was uneventful, and the patient was discharged on postoperative day 15 on warfarin anticoagulation. At 12-month follow-up, the patient remained in New York Heart Association functional class I–II without thromboembolic complications, pump thrombosis, or device-related rehospitalization. Chest radiography and transthoracic echocardiography confirmed satisfactory LVAD position and unobstructed inflow cannula alignment (Figs 2 and 3).

For image description, please refer to the figure legend and surrounding text.
Figure 1

Intraoperative findings during HeartMate 3 implantation. (A) Left ventricular apical myocardial core removed during creation of the inflow cannula site. (B) Metallic leaflets and pivot/strut components extracted from the mechanical mitral prosthesis after intentional fragmentation. The prosthetic sewing ring was preserved in situ.

For image description, please refer to the figure legend and surrounding text.
Figure 2

Postoperative posteroanterior chest radiograph demonstrating appropriate position of the HeartMate 3 pump, inflow cannula, and retained radiopaque mitral prosthetic sewing ring. The implantable cardioverter-defibrillator generator and transvenous leads are visible in the left pectoral region.

For image description, please refer to the figure legend and surrounding text.
Figure 3

Follow-up transthoracic echocardiography (parasternal long-axis view) showing optimal apical alignment of the LVAD inflow cannula without interference from the retained mitral sewing ring. Effective left ventricular unloading with reduced cavity dimensions is evident. Mild residual tricuspid regurgitation and estimated pulmonary artery systolic pressure of 40 mmHg were also documented.

Discussion

Management of mechanical mitral valve prostheses during LVAD implantation remains controversial [3, 4]. Retaining the prosthesis may predispose to leaflet immobility, thrombosis, and inflow obstruction under continuous-flow conditions, whereas complete valve replacement increases operative complexity and bleeding risk, particularly in redo surgery [5, 6]. In this case, selective removal of the prosthetic leaflets and pivot components while preserving the sewing ring provided an alternative strategy that avoided annular reconstruction and maintained unobstructed inflow geometry. An additional advantage of this approach was facilitation of optimal inflow cannula alignment toward the mitral inflow axis, potentially improving ventricular washout and reducing thrombosis risk [7]. Concomitant tricuspid annuloplasty was also performed because of severe tricuspid regurgitation and increased risk of postoperative right ventricular dysfunction [8]. The patient remained free from thromboembolic or device-related complications at 12-month follow-up while receiving standard warfarin anticoagulation [9]. Although limited by the single-case design and relatively short follow-up, this experience suggests that selective prosthetic component removal with preservation of the sewing ring may represent a feasible option in carefully selected patients undergoing durable LVAD implantation [10–12].

Conclusion

A pre-existing mechanical mitral valve prosthesis should not be considered an absolute contraindication to durable LVAD implantation. In selected redo patients, removal of the prosthetic leaflets with preservation of the sewing ring may represent a feasible alternative to complete valve replacement. This strategy may optimize inflow cannula alignment while avoiding the additional morbidity of repeat mitral valve surgery. Further experience is required to confirm long-term safety and reproducibility.

Conflicts of interest

The author declares no conflicts of interest.

Funding

No funding was received for this case report.

Ethics statement

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

References

1.

Mehra
 
MR
,
Uriel
 
N
,
Naka
 
Y
 et al.  
A fully magnetically levitated left ventricular assist device - final report
.
N Engl J Med
 
2019
;
380
:
1618
27
.

2.

Saeed
 
D
,
Feldman
 
D
,
El Banayosy
 
A
 et al.  
The 2023 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: a 10-year update
.
J Heart Lung Transplant
 
2023
;
42
:
e1
222
.

3.

Wang
 
TS
,
Hernandez
 
AF
,
Felker
 
GM
 et al.  
Valvular heart disease in patients supported with left ventricular assist devices
.
Circ Heart Fail
 
2014
;
7
:
215
22
.

4.

Carr
 
MJ
,
Smith
 
SA
,
Slaughter
 
MS
 et al.  
Managing valvular pathology during LVAD implantation
.
Indian J Thorac Cardiovasc Surg
 
2023
;
39
:
101
13
.

5.

Khatri
 
W
,
Fortna
 
S
,
Hochstetler
 
A
 et al.  
Unpredictable mechanical mitral valve leaflet motion in a patient with continuous-flow LVAD
.
JACC Case Rep
 
2025
;
30
:
105710
.

6.

Kormos
 
RL
,
Teuteberg
 
JJ
,
Pagani
 
FD
 et al.  
Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes
.
J Thorac Cardiovasc Surg
 
2010
;
139
:
1316
24
.

7.

Veen
 
KM
,
Muslem
 
R
,
Soliman
 
OI
 et al.  
Left ventricular assist device implantation with and without concomitant tricuspid valve surgery: a systematic review and meta-analysis
.
Eur J Cardiothorac Surg
 
2018
;
54
:
644
51
.

8.

Veen
 
KM
,
Muslem
 
R
,
Soliman
 
OI
 et al.  
Left ventricular assist device implantation with and without concomitant tricuspid valve surgery: a systematic review and meta-analysis
.
Eur J Cardiothorac Surg
 
2018
;
54
:
644
51
.

9.

Ong
 
C
,
Dokos
 
S
,
Chan
 
B
 et al.  
Numerical investigation of the effect of cannula placement on thrombosis
.
Theor Biol Med Model
 
2013
;
10
:
35
.

10.

Mufti
 
HN
,
Elghobary
 
T
,
Murray
 
SK
 et al.  
Mitral valve and short-term ventricular assist devices; potential mechanical complications
.
Thorac Cardiovasc Surg Rep
 
2013
;
2
:
9
12
.

11.

Riebandt
 
J
,
Schaefer
 
A
,
Wiedemann
 
D
 et al.  
Concomitant cardiac surgery procedures during left ventricular assist device implantation: single-centre experience
.
Ann Cardiothorac Surg
 
2021
;
10
:
248
54
.

12.

Morgan
 
JA
,
Tsiouris
 
A
,
Nemeh
 
HW
 et al.  
Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices
.
J Heart Lung Transplant
 
2013
;
32
:
1255
61
.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.